Transthyretin mutations in hyperthyroxinemia and amyloid diseases

Human Mutation

Volumn 17, Issue 6, 2001, Pages 493-503

  Saraiva, Maria João Mascarenhas ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Amyloid; Amyloid cardiomyopathies; Amyloid neuropathies; Hyperthyroxinemia; Leptomeningeal amyloidosis; Transthyretin; TTR

Indexed keywords

LIGAND; PREALBUMIN; THYROXINE;

AMYLOIDOSIS; AUTOSOMAL DOMINANT INHERITANCE; BINDING AFFINITY; DISEASE ASSOCIATION; GENE MUTATION; HEART; HYPERTHYROXINEMIA; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; REVIEW;

AMYLOID; AMYLOID NEUROPATHIES; HUMANS; HYPERTHYROXINEMIA; MUTATION; PREALBUMIN;

EID: 0035018450     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.1132     Document Type: Review

References (116)

1. Almeida MR, Hesse A, Steinmetz A, Maisch B, Altland K, Linke RP, Gawinowicz MA, Saraiva MJ. 1991a. Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Card 86:567-571.
2. Almeida MR, Altland K, Rauh S, Gawinowicz MA, Moreira P, Costa PP, Saraiva MJ. 1991b. Characterization of a basic transthyretin variant TTR-Arg 102 in the German population. Bioch Biophys Acta 1097:224-226.
3. Almeida MR, Ferlini A, Forabosco A, Gawinowicz MA, Costa PP, Salvi F, Plasmati R, Tassinari C, Altland K, Saraiva MJ. 1992. Transthyretin variants (TTR Ala 49 and TTR Gln 89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat 1:211-215.
4. Almeida MR, Andreu FL, Qués MM, Costa PP, Saraiva MJ. 1993. Transthyretin Ala 71: a new transthyretin variant in a Spanish family with familial amyloidotic polyneuropathy. Hum Mutat 2:420-421.
5. Almeida MR, Alves IL, Terazaki H, Saraiva MJ. 2000. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy - TTR 104H and TTR T119M. Biochem Biophys Res Commun 270:1024-1028.
6. Altland K, Becker P, Banzhoff A. 1987. Paraffin oil protected high resolution hybrid isoelectric focusing for the demonstration of substitutions of neutral amino acids in denatured proteins: the case of four human transthyretin (prealbumin) variants associated with familial amyloidotic polyneuropathy. Electrophoresis 8:293-297.
7. Altland K. 1999. Common molecular characteristics of amyloidogenic TTR mutations. The 4th international symposium on FAP and other TTR related disorders. Umea, Sweden.
8. Altland K, Winter P. 1999. Potential treatment of transthyretin-type amyloidoses by sulfite. Neurogenetics 2:183-188.
9. Alves IL, Divino C, Schussler G, Altland K, Almeida MR, Palha JA, Coelho T, Costa PP, Saraiva MJM. 1993. Thyroxine binding in a TTR Met 119 kindred. J End Clin Lab 76:484-488.
10. Alves IL, Jacobson DR, Torres MF, Holmgren G, Buxbaum J, Saraiva MJ. 1996a. Transthyretin Ser6 as a neutral polymorphism in familial amyloidotic polyneuropathy. Amyloid 3:242-244.
11. Alves IL, Jacobson DR, Torres MF, Coelho T, Holmgren G, Saraiva MJ. 1996b. Compound heterozygosity in patients with TTR-related amyloidosis. Neuromuscul Disord (Suppl) 6:S19.
12. Alves IL, Altland K, Almeida MR, Winter P, Saraiva MJM. 1997. Screening and biochemical characterization of transthyretin variants in the Portuguese population. Hum Mutat 9:226-233.
13. Ando Y, Ohlsson P-I, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sandgren O, Uchino M, Ando M. 1996. A new simple and rapid screening method for variant transthyretin (TTR) related amyloidosis. Biochem Biophys Res Commun 228:480-483.
14. Andrade C. 1952. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75:408-427.
15. Araki S. 1984. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 6:128-133.
16. Blake CCF, Geisow MJ, Swan IDA, Rerat C, Rerat B. 1974. Structure of human plasma prealbumin at 2.5 A resolution. A preliminary report on the polypeptide chain conformation quaternary structure and thyroxine binding. J Mol Biol 88:1-12.
17. Booth DR, Soutar AK, Hawkins PN, Pepys MB. 1993. Three new amyloidogenic transthyretin gene mutations advantages of direct sequencing. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, editors. Amyloid and amyloidosis. Parthenon Publishing. p 456-458.
18. Booth DR, Tan SY, Hawkins PN, Pepys MB, Frustaci A. 1995. A novel variant of transthyretin, 59 (Thr)-(Lys), associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 91:962-967.
19. Booth DR, Booth SE, Persey MR, Tan SY, Madhoo S, Pepys MB, Hawkins PN. 1996. Three new amyloidogenic TTR mutations: Pro 12, Glu 18, Val 33. Neuromuscul Disord (suppl) 6:S20.
20. Booth DR, Gillmore JD, Persey MR, Booth SE, Cafferty KD, Tennent GA, Madhoo S, Whitehead TC, Pasvol G, Hawkins PN. 1998. Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy. Hum Mutat 12:135.
21. Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB, Morgan-Hughes JA. 1999. Transthyretin Leu12Pro is associated with systemic neuropathic and leptomeningeal amyloidosis. Brain 122: 183-190.
22. Camou F, Drunat S, Valleix S, Viemont M, Delpech M, Grateau G, Ellie E. 1999. A new mutant transthyretin Gly53Glu is associated with meningocerebrovascular amyloidosis in a Basque family. The 4th Int'l Symp on FAP and Other TTR Related Disorders. Umeå, Sweden, June, 1999.
23. Carvalho M, Moreira P, Evangelista T, Ducla-Soares JL, Bento M, Fernandes R, Saraiva MJ. 2000. New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy. Muscle and Nerve 23:1016-1021.
24. Coelho T, Chorão R, Sousa A, Alves IL, Torres MF, Saraiva MJM. 1996. Compound heterozygotes of transthyretin Met 30 and transthyretin Met 119 are protected from the devastating effects of familial amyloid polyneuropathy. Neuromuscul Disord (suppl) 6:S20.
25. Connors LH, Theberge R, Skare J, Costello CE, Falk RH, Skinner M. 1999a. A new transthyretin variant (Asn23) associated with familial amyloidosis in a Portuguese patient. Amyloid 6:114-118.
26. Connors LH, Ericsson T, Skare J, Amico A, Jones LA, Lewis WD, Skinner M. 1999b. Screening for plasma transthyretins using isoelectric focusing (IEF), a test for familial transthyretin amyloidosis (ATTR). In: Kyle RA, Gertz MA, editors. Amyloid and amyloidosis. Parthenon Publishing, p 303-305.
27. Date Y, Nakazato M, Kangawa K, Shirieda K, Fujimoto T, Matsukura S. 1997. Detection of three transthyretin gene mutation in familial amyloidotic polyneuropathy by analysis of DNA extracted form formalin-fixed and paraffin-embedded tissues. J Neurol Sci 150:143-148.
28. De Lucia R, Mauro A, Di Scapio A, Buffo A, Mortara P, Orsi L, Schiffer D. 1993. A new mutation on the transthyretin gene (Ser 112 Ile) causes an amyloid neuropathy with severe cardiac impairment. Clin Neuropathol 12:344.
29. Dupuy O, Bletry O, Blanc AS, Droz D, Viemont M, Delpech M, Grateau G. 1998. A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid 5:285-287.
30. Dwulet FE, Benson MD. 1986. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 78:880-886.
31. Ernstrom U, Petterson T, Jornvall H. 1995. A yellow component associated with human transthyretin has properties like a pterin derivative, 7, 8-dihydropterin-6-carboxaldehyde. FEBS Lett 360:177-182.
32. Ferlini A, Salvi F, Patrosso C, Fini S, Vezzoni P, Forabosco A. 1994. A new mutation (TTR Ala-47) in the transthyretin gene associated with hereditary amyloidosis TTR-related. Hum Mutat 4:61-64.
33. Ferlini A, Rapezzi C, Magnani B, Winter P, Altland K, Vezzoni P, Patrosso MC. 1996. A compound heterozygous patient for two TTR mutations affected with restrictive amyloidotic cardiomyopathy. Neuromuscul Disord (suppl) 6:S23.
34. Gillmore JD, Booth DR, Pepys MB, Hawkins PN. 1999. Familial amyloid polyneuropathy in an Afro-Caribbean patient associated with a novel transthyretin variant, serine 120. The 4th international symposium on FAP and other TTR related disorders. Umea, Sweden.
35. Goldsteins SG, Persson H, Andersson K, Olofsson A, Dacklin I, Edvinsson, Saraiva MJ, Lundgren E. 1999. Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants. Proc Natl Acad Sci USA 96:3108-3113.
36. Herbert J, Wilcox JN, Pham KC, Fremeau RT, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman D, Zimmerman EA, Roberts JL, Schon EA. 1986. Transthyretin: a choroid plexus specific transport protein in human brain. Neurology 36:900-911.
37. Holmgren G, Haetner E, Nordenson I, Sandgren O, Steen L, Lundgren E. 1988. Homozygosity for the transthyretin-met 30-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin Genet 34:333-338.
38. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB. 1993. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341:1113-1116.
39. Holmgren G, Costa PMP, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, Teixeira A, Saraiva MJM, Costa PP. 1994. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 31:351-354.
40. Ii S, Minnerath S, Ii K, Dyck PJ, Sommer SS. 1991. Two tiered DNA based diagnosis of transthyretin amyloidosis reveals two novel point mutations. Neurology 41:893-898.
41. Inoue H, Domingues FS, Damas AM, Saraiva MJ, Lundgren E, Sandgren O, Kirschner DA. 1998. Analysis of x-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: axially arrayed TTR monomers constitute the protofilament. Amyloid 5:163-174.
42. Izumoto S, Martone RL, Younger D, Hays AP, Herbert J. 1992. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation: Asn 70. Neurology 42:2094-2102.
43. Izumoto S, Kornberg J, Herbert J. 1993. Two transthyretin mutations associated with euthyroid hyperthyroxinemia. J Reumatol 20:186.
44. Jacobson DR, McFarlin DE, Kane I, Buxbaum JN. 1992. Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89:353-356.
45. Jacobson DR, Gertz MA, Kane I, Buxbaum JN. 1993. Genetic analysis of 9 unrelated patients with transthyretin (TTR)-cardiac amyloidosis: correlation of clinical and genetic findings and description of 2 new TTR variants. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T Young I, editors. Amyloid and amyloidosis. Parthenon Publishing. p 474-476.
46. Jacobson DR, Buxbaum JN. 1994. A double-variant transthyretin allele (Ser 6, Ile 33) in the Israeli patient "SKO" with familial amyloidotic polyneuropathy. Hum Mutat 3:254-260.
47. Jacobson DR, Gertz MA, Buxbaum JN. 1994. Transthyretin Val 107, a new variant associated with familial cardiac and neuropathic amyloidosis. Hum Mutat 3:399-401.
48. Jacobson DR, Alves IL, Saraiva MJ, Thibodeau SN, Buxbaum JN. 1995. Transthyretin Ser6 gene frequency in individuals without amyloidosis. Hum Genet 95:308-312.
49. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum J. 1997. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. The New England Journal of Medicine 336:466-473.
50. Jacobson DR, Kane I, Pan T, Tufau P, Gertz MA, Gallo G, Buxbaum JN. 1999. Late-onset cardiac amyloidosis and transthyretin variants: distinguishing between senile cardiac amyloidosis and familial amyloid cardiomyopathy. The 4th International Symposium on FAP and other TTR related disorders. Umea, Sweden.
51. Janunger T, Anan I, Holmgren G, Lovheim O, Ohlsson PL, Suhr OB, Tashima K. 2000. Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene. Amyloid 7:137-140.
52. Jenne DE, Denzel K, Blatzinger P, Winter P, Ohermaier B, Linke RP, Altland K. 1996. A new isoleucine substitution Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci USA 93:6302-6307.
53. Jones LA, Skare J, Harding J, Cohen A, Milunsky A, Skinner M. 1991. Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy. Am J Hum Genet 48:979-982.
54. Jones LA, Skare JC, Cohen AS, Harding JA, Milunsky A, Skinner M. 1992. Familial amyloid polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clin Genet 41:70-73.
55. Kishikawa M, Nakanishi T, Miyazaki A, Hatanaka M, Shimizu A, Tamoto S, Ohsawa N, Hayashi H, Kanai M. 1998. A new non-amyloid transthyretin variant, [G101S], detected by electrospray ionization/mass spectrometry. Hum Mutat 12:363.
56. Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A, Kusaka H, Fukui M, Nishine T. 1999. A new amyloidogenic transthyretin variant [D38A] detected by electrospray ionization/mass spectrometry. Amyloid 6:278-281.
57. Klein CJ, Nakamura M, Jacobson DR, Lacy MQ, Benson MD, Petersen RC. 1998. Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology 51:1462-1464.
58. Kohno K, Palha JA, Miyakawa K, Saraiva MJ, Ito S, Mabuchu T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, Gottesman ME, Shimada K, Takahashi K, Yamamura K, Maeda S. 1997. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 150:1497-1508.
59. Lachmann HJ, Booth DR, Bybee A, Hawkins PN. 2000. Transthyretin Ala97Ser is associated with familial amyloidotic polyneuropathy in a Chinese-Taiwanese family. Hum Mutat 16:180.
60. Misrahi M, Planté-Bordeneuve V, Lalu T, Serre L, Adams D, Lacroix DC, Said G. 1998. New transthyretin variants Ser91 and Ser116 associated with familial amyloidotic polyneuropathy. Hum Mutat 12:71.
61. Munar-Qués M, Costa PP, Saraiva MJM, Farré CV, Bernat CM, Luna CC, Alberti JFF. 1997. Familial amyloidotic polyneuropathy. TTR Met 30 in Majorca (Spain). Amyloid 4:181-186.
62. Munar-Qués M, Saraiva MJ, Calonge JO, Moreira P, Vidal PR, Pujol XP, Abel MJ, Alter JMB. 2000. Familial amyloid polyneuropathy in a Spanish family with a transthyretin deletion (Val122) presenting with carpal tunnel syndrome. Clin Genet 58:411-412.
63. Murakami T, Maeda S, Yi S, Ikegawa S, Kawashima E, Onodera S, Shimada K, Araki S. 1992. A novel transthyretin mutation associated with familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 182:520-526.
64. Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, Ando M. 1994. Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 44:315-318.
65. Nakamura M, Yamashita T, Ando Y, Hamidi Asi K, Tashima K, Ohlsson P, Kukuse Y, Benson MD. 1999. Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic Rnase cleavage assay. Hum Hered 49:186-189.
66. Nakamura M, Asl KH, Benson MD. 2000. A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy. Amyloid 7:46-50.
67. Nakazato M, Kangawa K, Minamino N, Tawara S, Matsuo H, Araki S. 1984. Revised analysis of amino acid replacement in a prealbumin variant (SKO-III) associated with familial amyloidotic polyneuropathy of Jewish origin. Biochem Biophys Res Commun 123:921-928.
68. Nakazato M, Ikeda S, Shiomi K, Matsukura S, Yoshida K, Shimizu H, Atsumi T, Kangawa K, Matsuo H. 1992. Identification of a novel transthyretin variant (Val30 Leu) associated with familial amyloidotic polyneuropathy. FEBS Letters 306:206-208.
69. Nichols WC, Liepnieks JJ, McKusick VA, Benson MD. 1989. Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics 5:535-540.
70. Nordlie M, Sletten K, Husby G, Ranlov PJ. 1988. A new prealbumin variant in familial amyloidotic cardiomyopathy of Danish origin. Scand J Immunol 27:119-122.
71. Palha JA, Moreira P Wisniewski T, Frangione B, Saraiva MJ. 1997. C for T substitution at codon 108: the first identified silent mutations in the transthyretin gene. Amyloid 4:52-53.
72. Palha JA, Ballinari D, Amboldi N, Cardoso I, Fernandes R, Bellotti V, Merlini G, Saraiva MJ. 2000a. 4′-Iodo-4′-deoxydoxorubicin (I-DOX) disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 156:1919-1925.
73. Palha JA, Fernandes R, Escobar GM, Episkopou V, Gottesman M, Saraiva MJ. 2000b. Transthyretin regulates thyroid hormone levels in the choroid plexus but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology 141:3267-3272.
74. Palha JA, Moreira P, Olofsson A, Lundgren E, Saraiva MJ. Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy. J Mol Med, in press.
75. Patrosso MC, Salvi F, DeGrandis D, Vexoni P, Jacobson DR, Ferlini A. 1998. Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis. Am J Med Genet 77:135-138.
76. Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A, Gali M, Estes M, Gambetti P. 1997. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41:70-73.
77. Planté-Bordencuve V, Lalu T, Misrahi M, Reilly MM, Adams D, Lacroix C, Said G. 1998. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 51:708-714.
78. Planté-Bordeneuve V, Ferreira A, Misrahi M, Adams D, Said G. 1999. Genotypic and phenotypic spectrum of transthyretin amyloidosis in the French population. The 4th international symposium on FAP and other TTR related disorders. Umea, Sweden.
79. Redondo C, Damas AM, Olofsson A, Lundgren E, Saraiva MJ. 2000a. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J Mol Biol 304:461-470.
80. Redondo C, Damas AM, Saraiva MJ. 2000b. Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity. Biochem J 348:167-172.
81. Reilly MM, Adams D, Booth DR, Davis MB, Said G. 1995. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 118:849-856.
82. Saeki Y, Ueno S, Yorifuji S, Sugiyama Y, Ide Y, Matsuzawa Y. 1991. New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis. Biochem Biophys Res Commun 180: 380-385.
83. Saeki Y, Ueno S, Takahashi N, Soga F, Yanagihara T. 1992. A novel mutant (Transthyretin Ile 50) related to amyloid polyneuropathy-single-strand conformation polymorphism as a new genetic marker. FEBS Letters 308:35-37.
84. Saraiva MJM, Birken S, Costa PP, Goodman DS. 1984. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 74:104-119.
85. Saraiva MJM, Sherman W, Marboe C, Figueira A, Costa PP, Freitas AF, Gawinowicz MA. 1990. Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant. Scand J Immunol 32:341-346.
86. Saraiva MJM, Almeida MR, Alves IL, Moreira P, Gawinowicz MA, Costa PP, Rauh S, Banhzoff A, Altland K. 1991. Molecular analyses of an acidic transthyretin Asn 90 variant. Am J Hum Genet 48:1004-1008.
87. Saraiva MJ, Almeida MR, Sherman W, Gawinowicz MA, Costa PM, Costa PP, Goodman DS. 1992. A new transthyretin mutation associated with amyloid cardiomyopathy. Am J Hum Genet 50:1027-1030.
88. Saraiva MJM, Torres MF, Serra J, Ochoa J. 1999. A new transthyretin variant - ATTR Arg104Cys. Amyloid 6:149-151.
89. Sasaki H, Sakaki Y, Matsuo H, Goto I, Kuroiwa Y, Sahashi I, Takahashi A, Shinoda T, Isobe T, Takagi Y. 1984. Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques. Biochem Biophys Res Commun 125: 636-642.
90. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y. 1985. Structure of the chromosomal gene for human serum prealbumin. Gene 37:191-197.
91. Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB. 1990. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 258:R338-R345.
92. Sebastiao MP, Saraiva MJ, Damas AM. 1998. The crystal structure of amyloidogenic Leu55-> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem 273:24715-24722.
93. Shiomi K, Nakazato M, Matsukura S, Ohnishi A, Hatanaka H, Tsuji S, Murai Y, Kojima M, Kangawa K, Matsuo H. 1993. A basic transthyretin variant (Glu61 Lys) causes familial amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced mutation restriction analysis. Biochem Biophys Res Commun 194:1090-1096.
94. Skare J, Jones LA, Myles N, Kane K, Milunsky A, Cohen A, Skinner M. 1994. Two transthyretin mutations (glu42gly, his90asn) in an Italian family with amyloidosis. Clin Genet 45:281-284.
95. Skinner M, Harding J, Skare I, Jones LA, Cohen AS, Milunsky A, Skare J. 1992. A new transthyretin mutation associated with amyloidotic vitreous opacities - asparagine for isoleucine at position 84. Ophtalmology 99:503-508.
96. Sousa A, Coelho T, Barros J, Sequeiros J. 1995. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-Type I in Póvoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 60:512-521.
97. Sousa MM, Berglund L, Saraiva MJ. 2000. Transthyretin in high density lipoproteins - association via apolipoprotein Al. J Lipid Res 41:58-65.
98. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. 1998. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66: 229-233.
99. Terazaki H, Ando Y, Misumi S, Nakamura M, Ando E, Matsunaga N, Shoji S, Okuyama M, Ideta H, Nakagawa K, Ishizaki T, Ando M, Saraiva MJ. 1999. A novel compound heterozygote (FAP ATTR Arg 104His/Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels. Biochem Biophys Res Commun 264:365-370.
100. Theberge R, Connors L, Skare J, Skinner M, Falk RH, Costello CE. 1999. A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient. Amyloid 6:54-58.
101. Togashi S, Watanabe H, Nagasaka T, Shindo K, Shiozawa Z, Maeda S, Tawata M, Onaya T. 1999. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54. Neurology 53:637-639.
102. Torres MF, Almeida MR, Saraiva MJ. 1995. TTR exon scanning in peripheral neuropathies. Neuromusc Disord 5:187-191.
103. Uemichi T, Murrell JR, Zeldenrust S, Benson MD. 1992. A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J Med Genet 29:888-891.
104. Uemichi T, Liepniecks JJ, Altland K, Benson MD. 1994. Identification of a novel non-amyloidogenic transthyretin polymorphism (His-74) in the German population. Amyloid 1:149-153.
105. Uemichi T, Gertz MA, Benson MD. 1995. A new transthyretin variant (Ser24) associated with familial amyloid polyneuropathy. J Med Genet 32:279-281.
106. Uemichi T, Liepniecks JJ, Benson MD. 1997. A trinucleotide deletion in the transthyretin gene (delta V122) in a kindred with familial amyloidotic polyneuropathy. Neurology 48:1667-1670.
107. Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. 1999. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 56:1152-1155.
108. Ueno S, Uemichi T, Takahashi N, Soga F, Yorifuji S, Tarui S, 1990a. Two novel variants of TTR identified in Japanese cases with familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 169:1117-1121.
109. Ueno S, Uemichi T, Yorifuji S, Tarui S. 1990b. A novel variant of transthyretin (Tyr 114 to Cys) deduced from the nucleotide sequences of the gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem Biophys Res Commun 169:143-147.
110. Vidai R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, Frangione B, Wisniewski T. 1996. Meningocerebrovascular amyloidosis associated with a novel transthyretin missense mutation at codon 18 (TTRD18G). Am J Pathol 148:361-366.
111. Wallace MR, Dwulet FE, Conneally PM, Benson MD. 1986. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 78:6-12.
112. Wallace MR, Dwulet FE, Williams EC, Conneally PM, Benson MD. 1988. Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest 81:189-193.
113. Westermark P, Sletten K, Johansson B, Cornwell GG III. 1990. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843-2845.
114. Yasuda T, Sobue G, Doyu M, Nakazato M, Shiomi K, Yanagi T, Mitsuma T. 1994. Familial amyloidotic polyneuropathy with late-onset and well preserved autonomie function -a Japanese kindred with novel mutant transthyretin (Ala 97 to Gly). J Neurol Sci 121:97-102.
115. Yoshioka K, Furuya H, Sasaki H, Saraiva MJM, Costa PP, Sakaki Y. 1989. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val Met mutation most common to the disease. Hum Genet 82:9-13.
116. Zeldenrust S, Skinner M, Harding J, Skare J, Benson MD. 1994. A new transthyretin variant (His-69) associated with vitreous amyloid in an FAP family. Amyloid 1:17-22.